
Sino Biopharmaceutical Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sino Biopharmaceutical Limited
Access all reports
Sino Biopharmaceutical Limited is a Chinese pharmaceutical company focused on the research, development, manufacturing, and distribution of a wide range of pharmaceutical products. The company’s portfolio covers therapeutic areas such as oncology, hepatitis, cardiovascular, orthopedics, and respiratory diseases. Sino Biopharmaceutical emphasizes innovation through its research and development efforts, producing both innovative and generic drugs to meet healthcare needs in China and internationally. The company is headquartered in Beijing, China, and its shares are listed on the Hong Kong Stock Exchange.
Key slides for Sino Biopharmaceutical Limited


H1 2024
Sino Biopharmaceutical Limited


H2 2024
Sino Biopharmaceutical Limited
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
1177
Country
🇭🇰 Hong Kong